(Q34603561)

3 August 2017

Muscle ring finger 1 mediates cardiac atrophy in vivo (English)

1 reference

3 August 2017

Monte S Willis

1

1 reference

3 August 2017

Mauricio Rojas

2

1 reference

3 August 2017

Luge Li

3

1 reference

3 August 2017

Craig H Selzman

4

1 reference

3 August 2017

Ru-Hang Tang

5

1 reference

3 August 2017

William E Stansfield

6

1 reference

3 August 2017

Jessica E Rodriguez

7

1 reference

3 August 2017

David J Glass

8

1 reference

3 August 2017

Cam Patterson

9

1 reference

3 August 2017

23 January 2009

1 reference

American Journal of Physiology Heart and Circulatory Physiology

3 August 2017

1 reference

3 August 2017

296

1 reference

3 August 2017

H997-H1006

1 reference

3 August 2017

4

1 reference

describes a project that uses

3 August 2017

ImageJ

1 reference

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC2670686/fullTextXML

inferred from PubMed Central ID database lookup

cites work

Appetite for destruction: E3 ubiquitin-ligase protection in cardiac disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670686

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670686

Muscle RING-finger protein-1 (MuRF1) as a connector of muscle energy metabolism and protein synthesis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670686

The E3 Ligase MuRF1 degrades myosin heavy chain protein in dexamethasone-treated skeletal muscle

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670686

Myosin accumulation and striated muscle myopathy result from the loss of muscle RING finger 1 and 3

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670686

Characterization of a model to independently study regression of ventricular hypertrophy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670686

Molecular determinants for the recruitment of the ubiquitin-ligase MuRF-1 onto M-line titin

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670686

LVAD-induced reverse remodeling: basic and clinical implications for myocardial recovery

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670686

Mechanical stress-strain sensors embedded in cardiac cytoskeleton: Z disk, titin, and associated structures

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670686

MURF-1 and MURF-2 target a specific subset of myofibrillar proteins redundantly: towards understanding MURF-dependent muscle ubiquitination

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670686

Muscle-specific RING finger 1 is a bona fide ubiquitin ligase that degrades cardiac troponin I

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670686

Muscle ring finger protein-1 inhibits PKC{epsilon} activation and prevents cardiomyocyte hypertrophy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670686

Hypertrophy of the heart: a new therapeutic target?

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670686

Protein degradation and protection against misfolded or damaged proteins

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670686

Cardiac hypertrophy: the good, the bad, and the ugly

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670686

Muscle-specific RING finger-1 interacts with titin to regulate sarcomeric M-line and thick filament structure and may have nuclear functions via its interaction with glucocorticoid modulatory element binding protein-1

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670686

Identification of ubiquitin ligases required for skeletal muscle atrophy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670686

Cardiac adverse effects of early dexamethasone treatment in preterm infants: a randomized clinical trial

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670686

Four year follow up of aortic valve replacement for isolated aortic stenosis: a link between reduction in pressure overload, regression of left ventricular hypertrophy, and diastolic function

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670686

Prognostic value of left ventricular mass and its evolution during treatment in the Bordeaux cohort of hypertensive patients

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670686

Identification of muscle specific ring finger proteins as potential regulators of the titin kinase domain

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670686

Cardiac effects of short course dexamethasone in preterm infants

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670686

Hypertrophic cardiomyopathy associated with dexamethasone therapy for chronic lung disease in preterm infants

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670686

Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670686

Relation of Left Ventricular Mass and Geometry to Morbidity and Mortality in Uncomplicated Essential Hypertension

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670686

Hypertrophic cardiomyopathy associated with dexamethasone therapy for bronchopulmonary dysplasia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670686

Effect of clenbuterol on skeletal muscle atrophy in mice induced by the glucocorticoid dexamethasone

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2670686

Prognostic significance of left ventricular mass change during treatment of hypertension

7 July 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00660.2008

Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00660.2008

Cardiac improvement during mechanical circulatory support: a prospective multicenter study of the LVAD Working Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00660.2008

Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00660.2008

Irreversible cardiac changes after dexamethasone treatment for bronchopulmonary dysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00660.2008

Pharmacogenomics of left ventricular hypertrophy reversal: beyond the 'one size fits all' approach to antihypertensive therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00660.2008

Off-pump insertion of continuous flow left ventricular assist devices.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00660.2008

Conditional tetracycline-regulated expression of TGF-β1 in liver of transgenic mice leads to reversible intermediary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00660.2008

Muscle ring finger 1, but not muscle ring finger 2, regulates cardiac hypertrophy in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00660.2008

The generation of the oxidized form of creatine kinase is a negative regulation on muscle creatine kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00660.2008

Prognosis of left ventricular geometric patterns in the Framingham heart study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00660.2008

Association of change in left ventricular mass with prognosis during long-term antihypertensive treatment

21 January 2018

1 reference

12 December 2020

Aortic pressure, substrate utilization and protein synthesis

1 reference

12 December 2020

Left ventricular mass change during treatment and outcome in patients with essential hypertension

1 reference

12 December 2020

Regression of cellular hypertrophy after left ventricular assist device support

1 reference

12 December 2020

Changes in cardiovascular risk by reduction of left ventricular mass in hypertension: a meta-analysis

1 reference

12 December 2020

Canine dynamic left ventricular outflow tract obstruction: assessment of myocardial function and clinical outcome

1 reference

12 December 2020

Protein synthesis and degradation during regression of thyroxine-induced cardiac hypertrophy

1 reference

12 December 2020

Normalization of diastolic dysfunction in aortic stenosis late after valve replacement

1 reference

12 December 2020

Cardiac hypertrophy is not a required compensatory response to short-term pressure overload

1 reference

12 December 2020

Regression of left ventricular hypertrophy after surgical therapy for aortic stenosis is associated with changes in extracellular matrix gene expression

1 reference

12 December 2020

Activation of the cardiac proteasome during pressure overload promotes ventricular hypertrophy

1 reference

12 December 2020

ACE inhibitors captopril and enalapril induce regression of left ventricular hypertrophy in hypertensive patients with chronic renal failure

1 reference

12 December 2020

Prognostic significance of serial changes in left ventricular mass in essential hypertension

1 reference

12 December 2020

Proteasomal regulation of cardiac hypertrophy: is demolition necessary for building?

1 reference

12 December 2020

Cardiac protein synthesis and degradation during thyroxine-induced left ventricular hypertrophy

1 reference

12 December 2020

Early postnatal dexamethasone therapy for the prevention of chronic lung disease in preterm infants with respiratory distress syndrome: a multicenter clinical trial

1 reference

12 December 2020

Myostatin gene deletion prevents glucocorticoid-induced muscle atrophy

1 reference

12 December 2020

10.1152/AJPHEART.00660.2008

Identifiers

DOI

1 reference

3 August 2017

1 reference

3 August 2017

1 reference